Evidence map›Paper›PMID 25502805›Full record

ArticlePLoS genetics2014

A massively parallel pipeline to clone DNA variants and examine molecular phenotypes of human disease mutations.

Xiaomu Wei, Jishnu Das, Robert Fragoza, Jin Liang, Francisco M Bastos de Oliveira, Hao Ran Lee, Xiujuan Wang, Matthew Mort, Peter D Stenson, David N Cooper and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. In vivo versus in silico assessment of potentially pathogenic missense variants in human reproductive genes.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9.Frontiers in cell and developmental biology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. ExploringMicrobial cell (Graz, Austria) · 2021
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Xiaomu WeiDepartment of Medicine, Weill Cornell College of Medicine, New York, New York, United States of America; Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Jishnu DasWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, New York, United States of America.
Robert FragozaWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, United States of America.
Jin LiangWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America.
Francisco M Bastos de OliveiraWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, United States of America.
Hao Ran LeeWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, New York, United States of America.
Xiujuan WangWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, New York, United States of America.
Matthew MortInstitute of Medical Genetics, Cardiff University, Heath Park, Cardiff, United Kingdom.
Peter D StensonInstitute of Medical Genetics, Cardiff University, Heath Park, Cardiff, United Kingdom.
David N CooperInstitute of Medical Genetics, Cardiff University, Heath Park, Cardiff, United Kingdom.
Steven M LipkinDepartment of Medicine, Weill Cornell College of Medicine, New York, New York, United States of America.
Marcus B SmolkaWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Molecular Biology and Genetics, Cornell University, Ithaca, New York, United States of America.
Haiyuan YuWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, United States of America; Department of Biological Statistics and Computational Biology, Cornell University, Ithaca, New York, United States of America.
Cornell University · USCardiff University · GB

Funding

Cellular Responses to DNA Replication StressR01GM097272 · NIGMS · CORNELL UNIVERSITY · PI SMOLKA, MARCUS · 2011 to 2020
$2.7M
Whole Genome Sequencing to Discover Familial Myeloma Risk GenesR01CA167824 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LIPKIN, STEVEN M, OFFIT, KENNETH · 2012 to 2016
$1.9M
Using Protein Interactome Networks to Understand the Functional Role of Coding DNR01GM104424 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LIPKIN, STEVEN M, YU, HAIYUAN · 2013 to 2016
$1.7M
NCI NIH HHS R01 CA167824NIGMS NIH HHS R01 GM097272NIGMS NIH HHS R01 GM104424
6 · The paper itself

Abstract

Understanding the functional relevance of DNA variants is essential for all exome and genome sequencing projects. However, current mutagenesis cloning protocols require Sanger sequencing, and thus are prohibitively costly and labor-intensive. We describe a massively-parallel site-directed mutagenesis approach, "Clone-seq", leveraging next-generation sequencing to rapidly and cost-effectively generate a large number of mutant alleles. Using Clone-seq, we further develop a comparative interactome-scanning pipeline integrating high-throughput GFP, yeast two-hybrid (Y2H), and mass spectrometry assays to systematically evaluate the functional impact of mutations on protein stability and interactions. We use this pipeline to show that disease mutations on protein-protein interaction interfaces are significantly more likely than those away from interfaces to disrupt corresponding interactions. We also find that mutation pairs with similar molecular phenotypes in terms of both protein stability and interactions are significantly more likely to cause the same disease than those with different molecular phenotypes, validating the in vivo biological relevance of our high-throughput GFP and Y2H assays, and indicating that both assays can be used to determine candidate disease mutations in the future. The general scheme of our experimental pipeline can be readily expanded to other types of interactome-mapping methods to comprehensively evaluate the functional relevance of all DNA variants, including those in non-coding regions.

Indexed as

DNA Copy Number VariationsMutagenesis, Site-DirectedMutationPhenotypeAdaptor Proteins, Signal TransducingAllelesChromatography, LiquidCloning, MolecularDNA Mutational AnalysisExomeGene Expression RegulationGene LibraryHEK293 CellsHigh-Throughput Nucleotide SequencingHumansMutL Protein Homolog 1Adaptor Proteins, Signal TransducingMLH1 protein, humanMutL Protein Homolog 1Nuclear Proteins

Identifiers

PMID25502805
PMCPMC4263371
OpenAlexW1969456625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.